Quick Login
CLOSE X
FRR FAMILY
FRR BOSS NEW
TRAINEE MILLIONAIRE
FRR FOREX
FRRBOSS SHAREPRO
FRR RE-KYC
Equity
Home/ Are You A Trader/  Market Info/  Company Profile/  Quarterly Results

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2819.00-1.85 (-0.07 %)
PREV CLOSE (Rs.) 2820.85
OPEN PRICE (Rs.) 2810.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1599
TODAY'S LOW / HIGH (Rs.)2780.50 2825.00
52 WK LOW / HIGH (Rs.)1924.3 3515.95
NSE2820.601.5 (+0.05 %)
PREV CLOSE( Rs. ) 2819.10
OPEN PRICE (Rs.) 2819.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2820.60 (254)
VOLUME 55776
TODAY'S LOW / HIGH(Rs.) 2780.00 2824.90
52 WK LOW / HIGH (Rs.)1921 3515.7

Quarterly Results

Type
Quarters
GO
Select year
(Rs.in Million)
Particulars
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
8051.70
9743.70
9494.20
10107.70
Total Expenditure
5539.70
6411.80
6575.00
6890.60
PBIDT (Excl OI)
2512.00
3331.90
2919.20
3217.10
Other Income
437.20
406.80
350.70
345.40
Operating Profit
2949.20
3738.70
3269.90
3562.50
Interest
4.20
5.80
0.90
2.70
Exceptional Items
NA
NA
NA
46.90
PBDT
2945.00
3732.90
3269.00
3606.70
Depreciation
155.20
147.20
188.00
168.60
Profit Before Tax
2789.80
3585.70
3081.00
3438.10
Tax
739.70
957.00
782.20
913.10
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
2050.10
2628.70
2298.80
2525.00
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
2050.10
2628.70
2298.80
2525.00
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
2050.10
2628.70
2298.80
2525.00
Equity Capital
1694.10
1694.10
1694.10
1694.10
Face Value (IN RS)
10.00
10.00
10.00
10.00
Reserves
NA
NA
NA
NA
Calculated EPS
12.10
15.52
13.57
14.90
Calculated EPS (Annualised)
48.41
62.07
54.28
59.62
No of Public Share Holdings
42351510.00
42351510.00
42351510.00
42351510.00
% of Public Share Holdings
25.00
25.00
25.00
25.00
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
31.20
34.20
30.75
31.83
PBIDTM%
36.63
38.37
34.44
35.25
PBDTM%
36.58
38.31
34.43
35.68
PBTM%
34.65
36.80
32.45
34.01
PATM%
25.46
26.98
24.21
24.98
 
Notes
Notes
Notes
Notes
Attention Investors KYC ASBA

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Privacy | Disclaimer | Copyright | Terms & Conditions | Investor Grievance | Advisory for Investor | Investor Charter And Complaints | Investor SEBI Scores |
Regulatory Information | Documents in Vernacular Languages | CDSL E-Voting | Link Pan and Aadhaar | Fund Transfer | Segregation And Monitoring Of Collateral At Client Level |
Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links
BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015
Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.
© 2015 FRR Shares. All Rights Reserved | Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :
Assamese Bengali Gujarati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "